Across TCGA pan-cancer cohorts, RNU6-1123P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-1123P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-1123P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1123P expression acts as an unfavorable survival marker.

STAD, KIRP, and LUSC are the cancer types where RNU6-1123P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.465	0.741	.004	36	view →
KIRP	DFS	Quartile	II,III,IV	0.411	0.792	.002	33	view →
LUSC	DFS	Tertile	III,IV	0.139	0.782	.001	18	view →
THCA	DFS	Tertile	All	0.781	0.948	.001	18	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
DLBC	OS	Tertile	All	0.613	0.945	.049	9	view →
GBM	DFS	Quartile	All	0.146	0.333	.002	6	view →
UCEC	DFS	Tertile	All	0.284	0.658	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

Exploration

Same gene, other analysis: RNU6-1123P tumor-vs-normal RNA expression · all RNU6-1123P data types